Shandong Kexing Bioproducts Co., Ltd.
Recombinant human granulocyte colony- stimulating factor injection\Filgrastim
rHu-G-CSF is one of main factors modulating granulocytopoiesis and selectively acts on megakaryocytic progenitors to stimulate its multiplication and differentiation as well as to enhance functions and quantity of neutral granulocytes.
It is produced by genetic engineering technology and has similar bioactivity in vivo as well as in vitro compared with natural human G-CSF.
Indication
Neutropenia and granulocytopenia induced by different causes such as chemotherapy, bone marrow transplant and etc.
Advantages
1. Use of pre-filled syringes can relieve the injection pain, prevent Iatrogenic infection, avoid the loss of 10% of dosage caused by dead space in traditional syringe and reduce the working amount of doctors and nurses.
2. Promote the growth of WBC, increase WBC, strengthen life.
3. Clinical trial shows that WHITE-C has the effect of promoting recovery of neutrophil and decreasing the severity and lasting duration of neutropenia after chemotherapy without severe adverse or toxic reaction. It exhibits excellent efficacy and safety.
Pharmaceutical particulars
1. This product is colorless sterile solution with pH4.0, and composed of HAc-NaAc buffer 10MM, mannitol 5% and Tween-80 0.004%.
2. Dosage: 75µg/ml, 150µg/ml, or 300µg/ml
3. Package: vial and pre-filled syringe
4. Standard: Current European Pharmacopoeia and internal requirements.
Shelf life and storage conditions
Finished products: store at 2-8℃ for two years
API (concentrated solution): store at 2-8℃ for two years
Contact Details
|
Shandong Kexing Bioproducts Co., Ltd. Tangwangshan Road, Mingshui Development Zone, Zhangqiu Tel: 86-513-83316484;86-513-83311011 Fax: 86-513-83316484 Email: sales@kexing.com
Homepage Address |
Key Contact: zhang sunnia |
